Next |
home / stock / lexx / lexx message board
Subject | By | Source | When |
---|---|---|---|
Dont get too excited down 11% pre market | PotsandPans420 | investorshub | 05/19/2023 12:18:24 PM |
Hope Springs Eternal! | Shawking | investorshub | 05/19/2023 4:33:47 AM |
Be interesting to see if we see any | PotsandPans420 | investorshub | 05/18/2023 8:09:02 PM |
https://www.globenewswire.com/en/news-release/2021/02/23/2180141/28124/en/Global | Shawking | investorshub | 05/18/2023 7:45:25 PM |
Rush of price activity and volume more news coming? | codfather | investorshub | 05/18/2023 6:00:14 PM |
Thanks! | adam69 | investorshub | 05/18/2023 2:45:18 PM |
https://www.accesswire.com/755703/Lexarias-Hormone-Study-Shows-Significant-Enhan | Shawking | investorshub | 05/18/2023 2:37:44 PM |
volume 157k in less than an hour. | adam69 | investorshub | 05/18/2023 2:09:13 PM |
$LEXX MomentumIts trading up | Tech99989 | investorshub | 05/18/2023 5:34:00 AM |
$LEXX Good read | PotsandPans420 | investorshub | 05/17/2023 10:53:41 PM |
short squeeze signal | adam69 | investorshub | 05/15/2023 5:25:04 PM |
Ted Ohashi-Let's Toke Business | Shawking | investorshub | 05/15/2023 4:54:48 PM |
$LEXX Price trading up | Shawking | investorshub | 05/14/2023 3:23:28 PM |
$LEXX The trading | hdhick | investorshub | 05/14/2023 2:53:04 AM |
and the shorts continue | Shawking | investorshub | 05/14/2023 1:15:08 AM |
$LEXX MomentumIts now last trade up | PotsandPans420 | investorshub | 05/13/2023 2:30:43 PM |
oh yeah news for the day | all4weed | investorshub | 05/13/2023 5:11:37 AM |
Long and strong lets hope im right | Shawking | investorshub | 05/12/2023 9:03:24 AM |
short data if anyone is interested | PotsandPans420 | investorshub | 05/12/2023 8:57:51 AM |
what does this mean? | all4weed | investorshub | 05/12/2023 3:03:00 AM |
News, Short Squeeze, Breakout and More Instantly...
Lexaria Bioscience Corp. Company Name:
LEXX Stock Symbol:
NASDAQ Market:
Lexaria Bioscience Corp. Website:
Lexaria Bioscience Corp. (NASDAQ: LEXX) , a global innovator in drug delivery platforms, is doubling down on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year. “The company is optimistic that the studies will yield positive results, not just in the potentia...
Lexaria, a global innovator in drug delivery platforms, has announced the successful completion of its second round of dosing for its human pilot study #2 The final study arm is set for completion in early July, and if successful, it will help remedy the downsides of swallowed administration ...
Lexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global innovator in drug delivery platforms, today announced it has hired a contract research organization (“CRO”) to oversee execution of the company’s 12-week chronic study GLP-1-H24-4. The study will evaluate various DehydraTECH...